Stock 300206 EDAN INSTRUMENTS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Edan Instruments, Inc.

Equities

300206

CNE100001252

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
10 CNY +1.32% Intraday chart for Edan Instruments, Inc. +9.53% -2.06%
Apr. 25 Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 29 Edan Instruments, Inc. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on May 6, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,411 4,200 10,616 8,133 6,973 5,918
Enterprise Value (EV) 1 2,918 3,727 9,658 7,372 6,027 4,994
P/E ratio 36.8 x 31.9 x 16.3 x 35.3 x 29.9 x 26.7 x
Yield 1.77% 2.38% 2.37% 1.47% 1.72% 2.03%
Capitalization / Revenue 3.44 x 3.7 x 4.58 x 4.97 x 4 x 3.05 x
EV / Revenue 2.94 x 3.28 x 4.17 x 4.51 x 3.46 x 2.58 x
EV / EBITDA 35.1 x 27.1 x 12.2 x 26 x 25.2 x 21.7 x
EV / FCF -73.7 x 247 x 22.3 x 155 x 30.8 x -946 x
FCF Yield -1.36% 0.4% 4.48% 0.65% 3.24% -0.11%
Price to Book 2.74 x 3.25 x 5.86 x 4.69 x 3.76 x 3.01 x
Nbr of stocks (in thousands) 585,000 581,722 581,722 577,653 579,663 579,663
Reference price 2 5.830 7.220 18.25 14.08 12.03 10.21
Announcement Date 4/23/19 4/27/20 3/14/21 3/23/22 3/28/23 3/28/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 992.7 1,136 2,319 1,636 1,742 1,938
EBITDA 1 83.17 137.6 793.9 283.7 239.1 230
EBIT 1 47.62 100.3 751.8 240.2 191.9 185.7
Operating Margin 4.8% 8.83% 32.42% 14.68% 11.02% 9.58%
Earnings before Tax (EBT) 1 85.35 127.8 750.4 247.2 243.8 221.4
Net income 1 92.65 131.9 653.2 231.4 233 221.3
Net margin 9.33% 11.6% 28.17% 14.14% 13.37% 11.42%
EPS 2 0.1584 0.2261 1.123 0.3990 0.4020 0.3818
Free Cash Flow 1 -39.57 15.08 432.6 47.56 195.5 -5.28
FCF margin -3.99% 1.33% 18.66% 2.91% 11.22% -0.27%
FCF Conversion (EBITDA) - 10.96% 54.49% 16.76% 81.75% -
FCF Conversion (Net income) - 11.44% 66.24% 20.55% 83.9% -
Dividend per Share 2 0.1030 0.1720 0.4330 0.2070 0.2070 0.2070
Announcement Date 4/23/19 4/27/20 3/14/21 3/23/22 3/28/23 3/28/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 493 473 959 761 947 924
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -39.6 15.1 433 47.6 195 -5.28
ROE (net income / shareholders' equity) 6.87% 9.96% 41.6% 12.8% 13% 11.6%
ROA (Net income/ Total Assets) 2.08% 4.27% 25% 6.97% 5.6% 5.22%
Assets 1 4,465 3,091 2,611 3,320 4,160 4,241
Book Value Per Share 2 2.130 2.220 3.110 3.000 3.200 3.390
Cash Flow per Share 2 0.4800 0.5500 1.300 1.270 1.650 1.620
Capex 1 36.6 52.9 49.1 73.6 42.4 51.1
Capex / Sales 3.68% 4.66% 2.12% 4.49% 2.43% 2.64%
Announcement Date 4/23/19 4/27/20 3/14/21 3/23/22 3/28/23 3/28/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
EDAN INSTRUMENTS, INC. Stock Edan Instruments, Inc.
-2.06% 801M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.15% 217B
DANAHER CORPORATION Stock Danaher Corporation
+6.60% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+9.86% 131B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+24.32% 106B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.95% 62.16B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.04% 51.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.89B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-1.43% 40.16B
RESMED, INC. Stock ResMed, Inc.
+24.40% 31.44B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. 300206 Stock
  4. Financials Edan Instruments, Inc.